Small molecule high throughput screen using AstraZeneca facilities

Summary

This MRC grant funds academic researchers to run a high throughput screen (HTS) using AstraZeneca's compound library of over two million molecules and its state-of-the-art screening facilities. It supports up to four projects per year, each lasting 12–18 months, with the goal of discovering potential starting points for small molecule medicinal drugs.